Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

被引:495
|
作者
O'Byrne, PM
Bisgaard, H
Godard, PP
Pistolesi, M
Palmqvist, M
Zhu, YJ
Ekström, T
Bateman, ED
机构
[1] St Josephs Hosp, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada
[2] Univ Hosp Copenhagen, COPSAC Clin Res Unit, Gentofte, Denmark
[3] Hop Arnaud Villeneuve, Serv Malad Resp & Bronchomotricite, Montpellier, France
[4] Univ Florence, Dept Crit Care, Sect Resp Med, Florence, Italy
[5] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, S-41345 Gothenburg, Sweden
[6] Beijing Union Med Coll Hosp, Resp Dept, Beijing, Peoples R China
[7] AstraZeneca R&D, Lund, Sweden
[8] Univ Cape Town, ZA-7925 Cape Town, South Africa
关键词
inhaled corticosteroids; long-acting beta(2)-agonists; management; single inhaler;
D O I
10.1164/rccm.200407-884OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Asthma control is improved by combining inhaled corticosteroids with long-acting beta(2)-agonists. However, fluctuating asthma control still occurs. We hypothesized that in patients receiving low maintenance dose budesonide/formoterol (bud/form), replacing short-acting beta(2)-agonist (SABA) reliever with as-needed bud/form would provide rapid symptom relief and simultaneous adjustment in anti-inflammatory therapy, thereby reducing exacerbations. In this double-blind, randomized, parallel-group study, 2,760 patients with asthma aged 4-80 years (FEV1 60-100% predicted) received either terbutaline 0.4 mg as SABA with bud/form 80/4.5 mug twice a day (bud/form + SABA) or bud 320 mug twice a day (bud + SABA) or bud/form 80/4.5 mug twice a day with 80/4.5 mug as-needed (bud/form maintenance + relief). Children used a once-nocte maintenance dose. Bud/form maintenance + relief prolonged time to first severe exacerbation (p < 0.001; primary endpoint), resulting in a 45-47% lower exacerbation risk versus bud/form + SABA (hazard ratio, 0.55; 95% confidence interval, 0.44, 0.67) or bud + SABA (hazard ratio, 0.53; 95% confidence interval 0.43, 0.65). Bud/form maintenance + relief also prolonged the time to the first, second, and third exacerbation requiring medical intervention (p < 0.001), reduced severe exacerbation rate, and improved symptoms, awakenings, and lung function compared with both fixed dosing regimens.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 50 条
  • [1] Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Maori with asthma
    Pilcher, Janine
    Patel, Mitesh
    Smith, Ann
    Davies, Cheryl
    Pritchard, Alison
    Travers, Justin
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    Harwood, Matire
    [J]. RESPIROLOGY, 2014, 19 (06) : 842 - 851
  • [2] Budesonide Formoterol as a Reliever Medication for Mild Asthma
    Krome, Susanne
    [J]. PNEUMOLOGIE, 2020, 74 (02): : 68 - 68
  • [3] Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma
    LIN Jiang-tao
    CHEN Ping
    ZHOU Xin
    SUN Tie-ying
    XIE Can-mao
    XIU Qing-yu
    YAO Wan-zhen
    YANG Lan
    YIN Kai-sheng
    ZHANG Yong-ming
    [J]. 中华医学杂志(英文版), 2012, (17) : 2994 - 3001
  • [4] Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
    Sears, Malcolm R.
    Radner, Finn
    [J]. RESPIRATORY MEDICINE, 2009, 103 (12) : 1960 - 1968
  • [5] Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
    Jenkins, Christine
    Eriksson, Goeran
    Bateman, Eric D.
    Reddel, Helen K.
    Sears, Malcolm R.
    Fageras, Malin
    Lindberg, Magnus B.
    O'Byrne, Paul M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma
    Lin Jiang-tao
    Chen Ping
    Zhou Xin
    Sun Tie-ying
    Xie Can-mao
    Xiu Qing-yu
    Yao Wan-zhen
    Yang Lan
    Yin Kai-sheng
    Zhang Yong-ming
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (17) : 2994 - 3001
  • [7] Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
    Bisgaard, Hans
    Lythgoe, Dan
    Jorup, Carin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
    Jorup, Carin
    Lythgoe, Dan
    Bisgaard, Hans
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)
  • [9] Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
    Kuna, P.
    Peters, M. J.
    Manjra, A. I.
    Jorup, C.
    Naya, I. P.
    Martinez-Jimenez, N. E.
    Buhl, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (05) : 725 - 736
  • [10] Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children
    Kew, Kayleigh M.
    Karner, Charlotta
    Mindus, Stephanie M.
    Ferrara, Giovanni
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):